HSBC Holdings’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Other funds holding NAUT
ACM
PA
CM
VCM
CA
CFM
ACI
ST
HSBC Holdings's NAUT Position: Q1 2026 in Review
HSBC Holdings held its Nautilus Biotechnolgy (NAUT) position steady in Q1 2026 at 49,449 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #2628.
HSBC Holdings first reported a position in NAUT in Q4 2021 and has held it in 18 quarters since. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.
- HSBC Holdings held 49,449 shares of Nautilus Biotechnolgy worth $190K as of Q1 2026.
- HSBC Holdings left its Nautilus Biotechnolgy share count unchanged in Q1 2026.
- Nautilus Biotechnolgy made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2628 holding.
- HSBC Holdings first reported a position in Nautilus Biotechnolgy in Q4 2021 and has held it in 18 quarters since.
- 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.